Debut Plus

₹487.65

▼ -9.34 -1.88%

As of 23 Oct 2026 · delayed

NSE Listed

Amrutanjan Health Care Ltd. (AMRUTANJAN)

Volume: 35,012Avg Vol 1W: 29,550Avg Vol 1M: 36,033.552W Range:₹476.5₹760.15
NSE BSE www.amrutanjan.com AI Report
Key Ratios
Checked 22h ago
Market Cap₹1,410 Cr
Current Price₹487.65
Previous Close₹496.99
High / Low (52w)₹760.15 / ₹476.5
Volume35,012
Avg Vol (1W)29,550
Avg Vol (1M)36,033.5
Stock P/E36.68
Book Value₹112.97
Dividend Yield—
ROE16.5%
ROA—
Revenue (TTM)₹470 Cr
Revenue Growth—
Profit Margin—
Total Debt₹0 Cr
Shares Outstanding—
Face Value₹1
EPS (TTM)₹17.58
P/B5.71
Debt / Equity0.01
50 DMA₹504.86
200 DMA₹544.54
Day change-1.88%
Price Chart
₹487.65▼ 32.36% · 1Y
₹743₹48814.2L
2025-10-27
2026-10-23

20-day avg volume: 36K shares

Pros
  • Healthy return on equity of 16.5%.
  • Company is almost debt-free.
Cons
  • Revenue fell 22% YoY.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹110 Cr₹123 Cr₹135 Cr₹94 Cr₹118 Cr₹141 Cr₹150 Cr₹103 Cr
EBITDA₹16 Cr₹26 Cr₹21 Cr₹11 Cr₹19 Cr₹28 Cr₹29 Cr₹8 Cr
Net Profit₹12 Cr₹19 Cr₹15 Cr₹8 Cr₹14 Cr₹19 Cr₹16 Cr₹4 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Revenue₹110 Cr₹148 Cr₹142 Cr₹145 Cr₹171 Cr₹192 Cr
EBITDA₹16 Cr₹19 Cr₹18 Cr₹21 Cr₹25 Cr₹33 Cr
Net Profit₹10 Cr₹10 Cr₹10 Cr₹12 Cr₹15 Cr₹21 Cr
EPS33.732.476.928.5110.3114.08
Balance Sheet
MetricMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Total Assets₹157 Cr₹124 Cr₹124 Cr₹120 Cr₹124 Cr₹140 Cr
Total Liabilities₹55 Cr₹47 Cr₹42 Cr₹31 Cr₹29 Cr₹32 Cr
Equity₹101 Cr₹77 Cr₹82 Cr₹89 Cr₹95 Cr₹109 Cr
Total Debt——————
Cash Flow
MetricMar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016
Operating₹10 Cr₹9 Cr₹14 Cr₹25 Cr₹28 Cr₹32 Cr
Investing₹-29 Cr₹14 Cr₹8 Cr₹16 Cr₹-5 Cr₹4 Cr
Financing₹20 Cr₹-27 Cr₹-14 Cr₹-14 Cr₹-12 Cr₹-13 Cr
Free Cash Flow₹10 Cr₹9 Cr₹14 Cr₹25 Cr₹28 Cr₹32 Cr
Shareholding
Promoter 46.52% Institutions 10.37% Public 43.11%
Efficiency & Working Capital
ROCE23.3%
Interest Coverage75.3
Dividend Payout—
Debtor Days51 d
Inventory Days17 d
Payable Days17 d
Cash Conversion Cycle51 d
Working Capital Days68 d
Shareholding Details

As of 2026-09-30

Promoter46.5%
FII3.5%
DII6.9%
Institutions10.4%
Public43.1%
Promoter Pledge0%
No. of Shareholders46,186
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Promoters50.6%50.6%50.6%46.5%46.5%46.5%46.5%46.5%46.5%46.5%46.5%46.5%
FIIs0.8%1.4%1.5%2.3%2.3%2.3%2.4%2.4%2.3%2.2%2.4%3.5%
DIIs6.9%7.3%7.3%10.6%11.1%11.4%12.7%12.9%13%12.7%12.3%6.9%
Public41.7%40.7%40.5%40.5%40.1%39.8%38.4%38.2%38.2%38.6%38.8%43.1%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders68,40462,66457,16954,53653,85651,67449,43147,95446,67545,80545,13546,186
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Goodhealth Holdings Private LimitedShareholding of Promoter and Promoter Group20.2%58,25,803
Sambhuprasad SivalenkaShareholding of Promoter and Promoter Group10.3%29,90,730
Ramaa Prabhakar ArikirevulaShareholding of Promoter and Promoter Group4.7%13,71,530
Sambhu Prasad SivalenkaShareholding of Promoter and Promoter Group3.6%10,40,171
Isif Equity Long-short FundPublic Shareholding3.5%10,01,891
Ramaa Prabhakar ArikirevulaShareholding of Promoter and Promoter Group3%8,72,535
Ramalingam GantiShareholding of Promoter and Promoter Group2.5%7,30,640
Aditya DeorahPublic Shareholding2.3%6,67,139
Amulya Kamakshi Priya ArikirevulaShareholding of Promoter and Promoter Group2.1%6,16,781
Pari Washington India Master Fund, LtdPublic Shareholding2%5,83,481
Investor Education And Protection Fund (iepf)Public Shareholding1.5%4,33,694
Dipak Kanayalal ShahPublic Shareholding1.2%3,34,000
Board of Directors
NameDesignationYear
S SambhuprasadChairman / Executive Director / M D / Promoter2026
Ramaa Prabhakar ArikirevulaNon-Exec & Non-Independent Dir2026
Muralidharan SwayambunathanIndependent Non Exe. Director2026
Meena Lochani RaghunathanIndependent Non Exe. Director2026
V NagarajIndependent Non Exe. Director2026
Ramaswami KrishnanIndependent Non Exe. Director2026
GAGAN PREET SINGHCS / Compliance Officer / General Manager - Legal2026
Segments — Product
SegmentRevenueShare
OTC Products₹328 Cr65.3%
Women's Hygiene₹140 Cr27.8%
Beverages₹32 Cr6.3%
Others₹3 Cr0.6%
Segments — Geography
RegionRevenueShare
India₹491 Cr97.8%
Other countries₹11 Cr2.2%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹1533
Corporate Actions
TypeDateValueRemark
forthcoming2026-09-11Dividend—
dividend2026-09-11₹2.9 (290%)Final
forthcoming2026-09-11Dividend (2.9/- per share)Final
forthcoming2026-08-11Board Meetings—
dividend2026-02-06₹1 (100%)Interim 2
dividend2025-11-18₹1 (100%)Interim 1
dividend2025-09-16₹2.6 (260%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2026000406
2026000406
2026000406
Insider / Designated-Person Trades

30 recent disclosure(s)

S JeyakanthDisposal · 1,400
Nageswaramma Private TrustDisposal · 3,40,275
Nageswaramma Private TrustDisposal · 8,32,725
Amulya Kamakshi Priya ArikirevulaAcquisition · 6,16,781
RAMAA P ARIKIREVULAAcquisition · 2,64,335
S SAMBHU PRASAD EXECUTOR TO THE ESTATE OF S RAMAYAMMADisposal · 22,54,790
Substantial Acquisitions (SAST)

1 disclosure(s)

Market31/07/2026 · 2,11,361
Company Information
Incorporated1936
ChairmanS Sambhuprasad
AuditorB S R & Co LLP
Investor Email[email protected]; customercare@amrutanjan.
🌐 www.amrutanjan.com ↗

📍 New 103 Old 42-45 LuzChurch Rd, Mylapore, Chennai, Tamil Nadu, 600004

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Amd IndustriesAmeya Precision Engineers Ltd.Amiable Logistics India Ltd.Amir Chand Jagdish Kumar (Exports) Ltd.AMJ Land Holdings LimitedAmines & Plasticizers Ltd.Anand Rathi Wealth Ltd.Anantam Highways TrustAnant Raj LimitedAnawil Wire and Engineering Ltd.Andhra Paper LimitedAndhra Sugars Ltd.All “A” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search